TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
87,583
|
82,790
|
73,838 |
Financial expenses |
16
|
54
|
16 |
Earnings before taxes |
-7,080
|
5,736
|
10,013 |
EBITDA |
-5,456
|
10,898
|
14,031 |
Total assets |
91,842
|
71,681
|
60,705 |
Current assets |
61,413
|
56,734
|
42,281 |
Current liabilities |
34,216
|
37,899
|
31,995 |
Equity capital |
57,532
|
31,270
|
26,486 |
- share capital |
115
|
54
![]() |
54 |
Employees (average) |
52
|
51
|
39 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.6%
|
43.6%
![]() |
43.6% |
Turnover per employee |
1,684
|
1,623
|
1,893 |
Profit as a percentage of turnover |
-8.1%
|
6.9%
|
13.6% |
Return on assets (ROA) |
-7.7%
|
8.1%
|
16.5% |
Current ratio |
179.5%
|
149.7%
|
132.1% |
Return on equity (ROE) |
-12.3%
|
18.3%
|
37.8% |
Change turnover |
4,793
|
8,952
|
11,039 |
Change turnover % |
6%
|
12%
|
18% |
Chg. No. of employees |
1
|
12
![]() |
12 |
Chg. No. of employees % |
2%
|
31%
|
44% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.